Pharvaris N.V.

NASDAQ: PHVS · Real-Time Price · USD
22.30
-0.69 (-3.00%)
At close: Aug 15, 2025, 3:59 PM
22.30
0.00%
After-hours: Aug 15, 2025, 04:10 PM EDT

Pharvaris Income Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Apr 30, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a 66.75K 64.33K 69.91K 61.59K 61.25K 44.01K 39.62K 35.89K 33.3K n/a n/a n/a n/a
Gross Profit
n/a n/a n/a -69.02K -66.75K -64.33K -69.91K -61.59K -61.25K -44.01K -39.62K -35.89K -33.3K n/a n/a n/a n/a
Operating Income
42.19M n/a -37.9M -34.38M -28.31M -26.48M -28.89M -1.38M -19.48M -23.59M -22.39M -21.38M -22.77M -12.36M -9.08M -15.2M -6.02M
Interest Income
1.2M n/a 1.98M n/a n/a n/a 66.58K 545.14K 106.53K 88.28 25.86 n/a 52.00 n/a n/a n/a n/a
Pretax Income
-46.04M -33.52M -41.48M -29.66M -27.73M -31.18M -23.45M 766.6K -22.57M -38.89M -10.89M -9.88M -15.99M -12.36M -9.08M -15.2M -6.02M
Net Income
-46.34M -34.76M -41.71M -29.73M -28.02M -31.91M -23.6M 733.08K -22.63M -39.2M -8.49M -12.62M -16.03M -12.34M -9.14M -15.2M -6.04M
Selling & General & Admin
11.27M 13.89M 12.12M 11.31M 9.8M 8.28M 7.67M 441.83K 7.33M 7.52M 8.3M 7.66M 5.87M 5.54M 4.37M 4.66M 3.77M
Research & Development
30.91M 31.2M 25.78M 23.07M 18.51M 18.14M 18.54M 937.5K 13.74M 16.05M 14.09M 13.72M 13.51M 10.7M 8.96M 8.06M 8.07M
Other Expenses
-84.37M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
-42.19M 45.09M 37.9M 34.38M 28.31M 26.42M 26.2M 1.38M 21.08M 23.57M 22.39M 21.38M 19.38M 16.24M 13.33M 12.73M 11.84M
Interest Expense
n/a n/a 9.13K n/a n/a 5.31K 4.97K 16K 3.09M n/a 25.86K 33.46K 45.06K n/a 69.81K 69.55K n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a -284.18K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
-42.19M 45.09M 37.9M 34.38M 28.31M 26.48M 26.2M 1.38M 21.08M 23.57M 22.39M 21.38M 19.38M 16.24M 13.33M 12.73M 11.84M
Income Tax Expense
302.67K 1.24M 230.09K 70.62K 285.12K 728.51K 146.27K 33.52K 60.66K 303.2K -2.4M 2.74M 38.72K -19.63K 68.19K 2.96K 18.59K
Shares Outstanding (Basic)
54.52M 54.07M 54.07M 53.94M 53.82M 52.29M 40.91M 34.56M 33.82M 33.82M 33.79M 33.58M 33.14M 33.14M 33.13M 33.13M 31.82M
Shares Outstanding (Diluted)
54.52M 54.07M 54.07M 53.94M 53.82M 52.29M 40.91M 34.56M 33.82M 33.82M 33.79M 33.58M 33.14M 33.14M 33.13M 33.13M 31.82M
EPS (Basic)
-0.85 -0.64 -0.77 -0.55 -0.52 -0.61 -0.58 0.02 -0.67 -1.16 -0.25 -0.38 -0.48 -0.37 -0.28 -0.46 -0.19
EPS (Diluted)
-0.85 -0.64 -0.77 -0.55 -0.52 -0.61 -0.58 0.02 -0.67 -1.16 -0.25 -0.38 -0.48 -0.37 -0.28 -0.46 -0.19
EBITDA
-42.08M -45M -37.86M -34.31M -28.25M -27.16M -26.19M -22.39M -21.01M -39.06M -22.35M -21.35M -22.74M -16.24M -13.3M -15.12M -11.84M
EBIT
-42.19M -45.09M -37.9M -34.38M -28.31M -27.18M -26.2M -22.46M -21.08M -38.98M -10.87M -9.85M -15.94M -16.24M -9.01M -15.13M -11.84M
Depreciation & Amortization
105.3K 90.96K 43.57K 68.68K 66.75K 64.33K 69.91K 61.59K 61.25K 44.01K 39.62K 35.89K 33.3K 33.37K 28.95K 11.99K 3.06K